PRESS PLUS 5 MG + 20 MG CAP DURA CT BL AL PLAS TRANS X 60
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1097401450145 -
GGREM
504113110051203 -
Código de barras
7896112400431
O que a fonte publica
- Detentor do registro
- BIOLAB SANUS FARMACEUTICA LTDA
- Princípios ativos
- BESILATO DE ANLODIPINO;CLORIDRATO DE BENAZEPRIL
- Embalagem
- 5 MG + 20 MG CAP DURA CT BL AL PLAS TRANS X 60
- Tipo de produto
- Similar
- Classe terapêutica
- C9B3 - INIBIDORES DA ECA ASSOCIADOS A ANTAGONISTAS DO CÁLCIO (C8)
Nomes pelos quais este registro é encontrado
- PRESS PLUS 5 MG + 20 MG CAP DURA CT BL AL PLAS TRANS X 60
- PRESS PLUS
- BESILATO DE ANLODIPINO
- CLORIDRATO DE BENAZEPRIL
Dados completos da fonte
{
"name": "PRESS PLUS 5 MG + 20 MG CAP DURA CT BL AL PLAS TRANS X 60",
"holder": "BIOLAB SANUS FARMACEUTICA LTDA",
"stripe": null,
"barcodes": [
"7896112400431"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "504113110051203",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "49.475.833/0001-06",
"priceRegime": "Regulado",
"productName": "PRESS PLUS",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "5 MG + 20 MG CAP DURA CT BL AL PLAS TRANS X 60",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "149.36",
"icms-12": "169.73",
"icms-17": "179.95",
"icms-18": "182.15",
"icms-19": "184.40",
"icms-20": "186.70",
"icms-21": "189.06",
"icms-22": "191.49",
"icms-23": "193.97",
"icms-17.5": "181.04",
"icms-19.5": "185.54",
"icms-20.5": "187.87",
"icms-22.5": "192.72",
"icms-12-alc": "167.69",
"icms-17-alc": "177.79",
"icms-18-alc": "179.96",
"icms-19-alc": "182.18",
"icms-20-alc": "184.46",
"icms-21-alc": "186.79",
"icms-22-alc": "189.19",
"icms-23-alc": "191.65",
"withoutTaxes": "147.57",
"icms-17.5-alc": "178.87",
"icms-19.5-alc": "183.31",
"icms-20.5-alc": "185.62",
"icms-22.5-alc": "190.41"
},
"pisCofinsList": "Positiva",
"substanceText": "BESILATO DE ANLODIPINO;CLORIDRATO DE BENAZEPRIL",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "205.88",
"icms-12": "233.96",
"icms-17": "248.04",
"icms-18": "251.07",
"icms-19": "254.18",
"icms-20": "257.35",
"icms-21": "260.60",
"icms-22": "263.95",
"icms-23": "267.37",
"icms-17.5": "249.54",
"icms-19.5": "255.75",
"icms-20.5": "258.96",
"icms-22.5": "265.64",
"icms-12-alc": "231.82",
"icms-17-alc": "245.78",
"icms-18-alc": "248.78",
"icms-19-alc": "251.85",
"icms-20-alc": "255.01",
"icms-21-alc": "258.23",
"icms-22-alc": "261.54",
"icms-23-alc": "264.94",
"withoutTaxes": "204.00",
"icms-17.5-alc": "247.28",
"icms-19.5-alc": "253.42",
"icms-20.5-alc": "256.61",
"icms-22.5-alc": "263.23"
},
"invalidBarcodes": [],
"activeSubstances": [
"BESILATO DE ANLODIPINO",
"CLORIDRATO DE BENAZEPRIL"
],
"therapeuticClass": "C9B3 - INIBIDORES DA ECA ASSOCIADOS A ANTAGONISTAS DO CÁLCIO (C8)",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1097401450145",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "C9B3",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:504113110051203"